scispace - formally typeset
B

Brian Wigdahl

Researcher at Drexel University

Publications -  229
Citations -  6653

Brian Wigdahl is an academic researcher from Drexel University. The author has contributed to research in topics: Virus & Long terminal repeat. The author has an hindex of 41, co-authored 215 publications receiving 5987 citations. Previous affiliations of Brian Wigdahl include Thomas Jefferson University & Pennsylvania State University.

Papers
More filters
Journal ArticleDOI

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy.

TL;DR: In this paper, a review examines the strengths, limitations, and origins of the different classes of off-target cleavage detection systems including anchored primer enrichment (GUIDE-seq), in situ detection (BLISS), in vitro selection libraries (CIRCLE-seq) and in vitro genomic DNA digestion (Digenome-seq and SITE-Seq).
Journal ArticleDOI

Characterization of a glial cell-specific DNA-protein complex formed with the human T cell lymphotropic virus type I (HTLV-I) enhancer.

TL;DR: Electrophoretic mobility shift analyses utilizing double-stranded oligonucleotides homologous to each of the 21 bp repeats and nuclear extracts derived from selected cell lines of lymphocytic, neuronal, and glial origin suggest that the differential binding of cellular factors may play a role in basal as well as Tax-mediated LTR-directed transcription within cell populations of either immune or nervous system origin.
Journal ArticleDOI

Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon.

TL;DR: The substitution of BVDU with 9-[(2-hydoxyethoxy)methyl]guanine (acyclovir; ACV) during a combined treatment with IFN-alpha inhibited HSV-1 replication and established in vitro virus latency that could be maintained for a longer period after inhibitor removal and a continued incubation at 37 degrees C.
Journal ArticleDOI

Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter.

TL;DR: The human immunodeficiency virus type 1 (HIV‐1) transactivator of transcription (Tat) protein functions both intracellularly and extracellularly, and its effects have been examined in HIV‐1‐associated neurocognitive disorders (HAND).